Fulcrum Therapeutics (FULC) Change in Acquisitions & Divestments (2020 - 2026)

Fulcrum Therapeutics (FULC) has 7 years of Change in Acquisitions & Divestments data on file, last reported at $27.1 million in Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 54.49% year-over-year to $27.1 million in Q1 2026; TTM through Mar 2026 was $178.8 million, a 1.14% increase from a year earlier, with the FY2025 full-year figure at $211.3 million, changed 0.07% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $27.1 million, up from $25.2 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for FULC reached as high as $94.0 million in Q1 2024 and fell as low as $23.9 million in Q4 2024.
• Historically, Change in Acquisitions & Divestments has averaged $45.5 million across 5 years, with a median of $42.9 million in 2022.
• Across the five-year window, Change in Acquisitions & Divestments soared 187.08% in 2024 and plunged 54.49% in 2026, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $47.0 million in 2022, then decreased by 7.52% to $43.5 million in 2023, then sank by 45.06% to $23.9 million in 2024, then gained by 5.64% to $25.2 million in 2025, then grew by 7.48% to $27.1 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $27.1 million in Q1 2026, $25.2 million in Q4 2025, and $36.0 million in Q3 2025.